PD 153035
Reference standard for [Methoxy-¹¹C]PD 153035
4-(3-Bromphenylamino)-6,7-bis(methoxy)quinazoline; 4-(3-Bromphenylamino)-6,7-dimethylquinazoline; AG 1517; NSC 669364; SU 5271; WHI-P 79
CA index name: 4-Quinazolinamine, N-(3-bromphenyl)-6,7-dimethoxy-
Quality
Research Chemical
Characteristics
Molar mass 360.21
CAS RN [153436-54-5]
Purity ≥ 95 %
- Yellowish solid
Certificates
CoA: appearance, ¹H NMR spectrum
Literature
Fredriksson A. et al. In vivo evaluation of the biodistribution of ¹¹C-labeled PD153035 in rats without and with neuroblastoma implants Life Sci. 1999, 65, 165–174.
Johnström P. et al. Synthesis of [Methoxy-¹¹C]PD153035, a Selective EGF Receptor Tyrosine Kinase Inhibitor J. Labelled Compd. Radiopharm. 1998, 41, 623–629.
Gibson K.H. et al. Epidermal growth factor receptor tyrosine kinase: Structure-activity relationships and antitumour activity of novel quinazolines Bioorg. Med. Chem. Lett. 1997, 7, 2723–2728.
Add to inquiry
Product | Product No. | Filling amount | Quantity | ||
---|---|---|---|---|---|
/products/small-molecules-and-peptides/chemical/fd9409e1-1729-4a7b-a8fa-82f98558e41c | Reference Standard | Product No.: 5210 | Filling amount: 10 mg | ||
/products/small-molecules-and-peptides/chemical/fd9409e1-1729-4a7b-a8fa-82f98558e41c | Reference Standard | Product No.: 5210 |